FDA Fast Track

AUSTIN, Texas | May 2026 Natera, Inc. announced a new collaboration with Diakonos Oncology Corp. to utilize its personalized...

DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...

CHICAGO, Ill., May 26, 2026 Emalex Biosciences announced that Phase 3 clinical data for ecopipam, its investigational dopamine-1 (D1)...

PARIS, France, May 18, 2026 Sanofi has announced positive Phase 2 ElevAATe trial results demonstrating that investigational therapy efdoralprin...

BOCA RATON, Fla., May 15, 2026 INmune Bio announced the publication of positive Phase 2 MINDFuL trial results for...

DURHAM, N.C., May 11, 2026 AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary...

LONDON, UK – May 11, 2026 GSK plc announced an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group) through...

SAN FRANCISCO and SUZHOU, China, May 10, 2026 Innovent Biologics, Inc. announced that China’s National Medical Products Administration (NMPA)...

MELVILLE, N.Y., May 7, 2026 BioRestorative Therapies announced expanded blinded Phase 2 clinical data for BRTX-100, its investigational autologous...

CAMBRIDGE, Mass., May 6, 2026 Clear Scientific Inc., a clinical-stage biopharmaceutical company developing innovative therapies for acute drug intoxication,...